Front Row Advisors LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$45,633
+108550.0%
448
+6.9%
0.02%
+10.5%
Q2 2023$42
+7.7%
4190.0%0.02%0.0%
Q1 2023$39
+2.6%
419
-0.7%
0.02%
-5.0%
Q4 2022$38
-99.9%
422
-15.3%
0.02%0.0%
Q3 2022$38,000
+26.7%
498
+38.3%
0.02%
+33.3%
Q2 2022$30,000
-9.1%
360
-3.2%
0.02%
+15.4%
Q1 2022$33,0000.0%372
-1.1%
0.01%
+8.3%
Q4 2021$33,000
+13.8%
376
+7.1%
0.01%0.0%
Q3 2021$29,000
-12.1%
3510.0%0.01%
-14.3%
Q2 2021$33,000
-10.8%
351
-18.2%
0.01%
-22.2%
Q1 2021$37,000
-9.8%
429
-0.2%
0.02%
-14.3%
Q4 2020$41,000
+5.1%
4300.0%0.02%0.0%
Q3 2020$39,000
-26.4%
430
-29.4%
0.02%
-36.4%
Q2 2020$53,000
+20.5%
609
+18.5%
0.03%
+10.0%
Q1 2020$44,000
+12.8%
514
+25.1%
0.03%
+20.0%
Q4 2019$39,000
+2.6%
411
-6.4%
0.02%
-7.4%
Q3 2019$38,000
-13.6%
439
-8.0%
0.03%
-15.6%
Q2 2019$44,000
-8.3%
477
-4.8%
0.03%
-13.5%
Q1 2019$48,000
+14.3%
501
+1.8%
0.04%0.0%
Q4 2018$42,000
+90.9%
492
+90.7%
0.04%
+146.7%
Q3 2018$22,000
+15.8%
258
+13.2%
0.02%
+25.0%
Q2 2018$19,000
+18.8%
228
+14.0%
0.01%
+9.1%
Q1 2018$16,000
-5.9%
2000.0%0.01%
-21.4%
Q4 2017$17,0002000.01%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders